Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,700.70
-28.00 (-1.62%)
At close: Jan 14, 2026
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.08 trillion as of January 14, 2026. Its market cap has decreased by -7.64% in one year.
Market Cap
4.08T
Enterprise Value
3.86T
Revenue
549.64B
Ranking
n/a
PE Ratio
39.05
Stock Price
1,700.70
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.08T, an increase of 14,678.87%. That is a compound annual growth rate of 22.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 4.15T | 0.52% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.71T |
| Cipla | 1.17T |
| Apollo Hospitals Enterprise | 1.05T |
| Mankind Pharma | 913.91B |
| Zydus Lifesciences | 906.31B |
| Alkem Laboratories | 701.07B |
| Fortis Healthcare | 685.50B |
| Aurobindo Pharma | 678.20B |